The patented nanoparticle technology solubilises pharmaceutical compounds in fatty acids and/or fatty alcohols. The formulation achieves aqueous form after dilution with equimolar of protonating agent, thereby keeping the
Prior to taking the helm at Unilever, Polman was a top executive of both Procter & Gamble and Nestle. Polman was chief financial officer and executive vice president
Dr Feingold’s experience in oncology and hematology will continue to drive the DSI’s current cardiovascular portfolio and shape its pipeline. He will also become a member of DSI’s
The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial
As a result, the Opposition Division of the European Patent Office has decided to revoke the Domantis patent in full. If this decision becomes final, all the claims
Ofirmev is Cadence’s proprietary intravenous formulation of Acetaminophen. Acetaminophen has been used as a medication for the treatment of pain and fever in the US, and is available
The company claims that Cobroxin is the first over-the-counter (OTC) pain reliever, clinically proven to treat moderate-to-severe (stage 2) chronic pain. Many other stage 2 drugs require prescriptions,
Benicar is an angiotensin II receptor blocker (ARB), which blocks the action of a substance in the body called angiotensin II that increases blood pressure. It is indicated
Reportedly, the study population will consist of patients ages 18 to 75 with symptoms of angina or myocardial ischemia. The primary endpoints are difference in Major Adverse Cardiac
The Alzheimer’s disease-specific antibodies were discovered using a platform being developed by OPKO that appears to be capable of identifying such biomarkers for any disease to which the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.